COMPANY · NIPC 507372328
Goldfarma Produtos Farmacêuticos, Lda
254 contracts on Portal BASE, worth €3,863,223.09 in total.
Identification
| Company name | Goldfarma Produtos Farmacêuticos, Lda |
|---|---|
| NIPC | 507372328 |
None of the registers we read (GLEIF, TED and contract documents) identifies this company; the name comes from Portal BASE contracts.
Contracted money
Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.
| Year | Contracts | Contract value |
|---|---|---|
| 2014 | 1 | €201,036.64 |
| 2015 | 2 | €398,297 |
| 2023 | 51 | €662,602.79 |
| 2024 | 63 | €883,690.96 |
| 2025 | 55 | €1,054,873.03 |
| 2026 | 82 | €662,722.67 |
| Name | Contracts | Contract value |
|---|---|---|
| Serviço de Intervenção nos Comportamentos Aditivos e nas Dependências | 4 | €908,515.64 |
| Unidade Local de Saúde da Arrábida, E. P. E. | 11 | €466,504.45 |
| Instituto para os Comportamentos Aditivos e as Dependências, I. P. | 2 | €338,409 |
| Unidade Local de Saúde do Algarve, E. P. E. | 3 | €282,651.97 |
| Centro Hospitalar de Setúbal, E. P. E. | 8 | €168,224.41 |
| Unidade Local de Saúde de Entre O Douro e Vouga, E.P.E | 5 | €153,944.19 |
| Unidade Local de Saúde de São José, EPE | 3 | €151,855 |
| Unidade Local de Saúde de São José, E. P. E. | 9 | €119,699.08 |
| Unidade Local de Saúde do Algarve, EPE | 2 | €114,703.61 |
| Instituto para os Comportamentos Aditivos e as Dependências, IP | 1 | €114,000 |
| Name | Contracts | Contract value |
|---|---|---|
| Lisboa | 60 | €1,723,430.62 |
| Setúbal | 19 | €634,728.86 |
| Faro | 16 | €493,282.80 |
| Santa Maria da Feira | 5 | €153,944.19 |
| Braga | 9 | €114,010.09 |
| Leiria | 12 | €92,262.38 |
| Loures | 10 | €90,805.86 |
| Viana do Castelo | 17 | €89,331.83 |
| Vila Nova de Gaia | 23 | €78,845.31 |
| Amadora | 7 | €69,077.50 |
| Subject | Year | Contract value |
|---|---|---|
| Aquisição de cloridrato de metadona | 2023 | €309,182 |
| Aquisição de cloridrato de metadona para o ano de 2015 | 2015 | €243,100 |
| Aquisição de Cloridrato de Metadona para o ano 2014 | 2014 | €201,036.64 |
| 61/8001/2024 - Autorização de Utilização Excecional do Medicamento | 2024 | €187,919.55 |
| Aquisição durante o ano de 2024 de comprimidos de cloridrato de metadona nas dosagens de 5, 10, 20 e 40 mg (cinco, dez, vinte e quarenta miligramas) | 2024 | €173,120 |
Who they competed with
In 366 contracts with a list of competitors, the company took part and was awarded 55 (15%).
The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.
Links read in contract documents
Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.
The documents we read show no links between these companies.
Investigations that mention it
No published investigation mentions this company by NIPC.